Brian E. Frosh, Attorney General of Maryland, et al., Petitioners v. Association for Accessible Medicines

  1. February 19, 2019

    High Court Won't Hear Fight Over Md. Price-Gouging Law

    The U.S. Supreme Court dealt a final blow Tuesday to a landmark Maryland law aimed at stopping generic-drug makers from price gouging when it refused to review the Fourth Circuit's decision that the law is unconstitutional. 

  2. January 14, 2019

    Skip Md.'s Bid To Revive Price-Gouging Law, Justices Urged

    The generic-drug industry on Monday urged the U.S. Supreme Court to turn down Maryland's attempt to revive a state law targeting price gouging, arguing that Maryland is attempting to skirt a "bedrock principle of federalism" by regulating what happens in other states.

  3. January 01, 2019

    Life Sciences Cases To Watch In 2019

    The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors' decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.

  4. October 19, 2018

    Md. Asks Justices To Revive Generic-Drug Price-Gouging Law

    Maryland's attorney general on Friday urged the U.S. Supreme Court to decide whether it violates the commerce clause for states to regulate the price of drugs manufactured outside of their borders, with the hopes of reviving an anti-price gouging law shot down by the Fourth Circuit.